E-therapeutics Plc

    E-therapeutics Plc

    OOTC:ETXPF
    - -
    USD
    - -
    - -
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    -0.04
    -0.02
    -0.03
    -0.02
    -0.03
    -0.03
    -0.05
    -0.02
    -0.01
    -0.01
    -0.01
    -0.02
    -0.02
    Free Cash Flow per Basic Share
    -0.03
    -0.03
    -0.03
    -0.02
    -0.04
    -0.04
    -0.04
    -0.02
    -0.01
    -0.01
    -0.01
    -0.02
    -0.02
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.12
    -0.08
    -0.11
    -0.08
    -0.1
    -0.14
    -0.18
    -0.2
    -0.22
    -0.23
    -0.17
    -0.15
    -0.15
    Tangible Book Value per Share
    - -
    0.11
    0.07
    0.17
    0.14
    0.1
    0.06
    0.04
    0.02
    0.02
    0.04
    0.06
    0.06
    Basic Weighted Avg Shares
    66
    131
    138
    254
    264
    264
    267
    268
    269
    269
    373
    488
    537
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -11,622.73
    -633.33
    -1,414.83
    -2,005.66
    -2,155.58
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    3
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -2
    -3
    -4
    -5
    -8
    -9
    -13
    -5
    -4
    -2
    -4
    -8
    -8
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -9,088.64
    -514.69
    -1,162.15
    -1,691.19
    -1,741.89
    Working Capital
    1
    14
    10
    44
    36
    28
    16
    11
    7
    4
    14
    27
    32
    LT Debt
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    - -
    15
    11
    45
    37
    28
    16
    11
    7
    5
    14
    28
    33
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    GBP

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    GBP

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    GBP

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    46.17%
    51.36%
    19.18%
    Free Cash Flow
    20.17%
    31.06%
    -6.17%
    Net Income, GAAP
    18.98%
    22.36%
    2.57%
    Sales/Revenue/Turnover
    - -
    - -
    -0.42%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    GBP

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    GBP

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    -0.02
    2023
    - -
    - -
    - -
    - -
    -0.02
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    GBP

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business